Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Banka BioLoo's Free Cash Flow for the
three
months ended in Mar. 2026 was ₹0.0 Mil. Banka BioLoo's Revenue for the
three
months ended in Mar. 2026 was ₹176.7 Mil. Therefore, Banka BioLoo's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical data trend for Banka BioLoo's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:BANKA vs VLTO, ZWS, CECO: FCF Margin % Comparison
For the Pollution & Treatment Controls subindustry, Banka BioLoo's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Banka BioLoo FCF Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Banka BioLoo's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Banka BioLoo's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Banka BioLoo (NSE:BANKA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Banka BioLoo and its competitors. According to the industry distribution chart, Banka BioLoo ranks #2324 out of 3042 companies in the Industrial Products industry, placing it in the top 76.4%.
Is Banka BioLoo's FCF Margin % too high?
Banka BioLoo's current FCF Margin % is 0.00%. Based on the distribution chart, Banka BioLoo ranks #2324 out of 3042 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Banka BioLoo has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Banka BioLoo's FCF Margin % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Banka BioLoo ranks #2324 out of 3042 companies for FCF Margin %. This places Banka BioLoo in the lower half of its industry. The industry median FCF Margin % is 1.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for an Industrial Products company?
The median FCF Margin % among Industrial Products companies is 1.55, based on 3,042 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Banka BioLoo and its competitors. For the Industrial Products industry, the median FCF Margin % is 1.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Banka BioLoo's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Banka BioLoo stock overvalued right now?
Based on GuruFocus' analysis, Banka BioLoo (NSE:BANKA) is currently considered Fairly Valued. The stock's GF Value™ is ₹87.15, compared to a current price of ₹90.32 — trading 3.6% above its estimated fair value. The current FCF Margin % is 0.00%. Banka BioLoo's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Banka BioLoo (NSE:BANKA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Banka BioLoo (NSE:BANKA) Overvalued in 2026?
Based on GuruFocus' analysis, Banka BioLoo stock appears to be overvalued.
The current stock price of ₹90.32 is trading 3.6% above its estimated GF Value™ of ₹87.15.
GuruFocus considers Banka BioLoo to be Fairly Valued.
Key valuation signals for NSE:BANKA:
FCF Margin %: 0.00%
GF Value™: ₹87.15 vs. price of ₹90.32 (3.6% above fair value)
No single metric tells the full story. See the NSE:BANKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Banka BioLoo Ltd provides sanitation infrastructures and human waste management solutions and services. It is engaged in the business of manufacturing, supplying, and installing Bio toilets, setting up Fecal Sludge Treatment Plants (FSTPs), waste water treatment plants, Effluent treatment plants, and their operation and maintenance. The company has only one reportable business segment, which is the manufacturing, supplying, and installation of Bio toilets and related AMOC services. It provides services to various schools, villages, resorts, indian railways, small communities, industrial factories, construction sites, and others. Geographically, the company operates only in India.
77GF Score
Get the complete analysis for NSE:BANKA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BANKA has been successfully added to your 
